Comunicación | April 6, 2021 ECH


  • The initiative is a pioneer in Europe, with national and international coverage, which combines diagnostic tests and the latest technology, to offer a joint solution that guarantees the health and safety of all attendees.
  • It responds to the needs of professionals in the sector by providing security and control solutions before, during and after the event.
  • Concerts, plays, sporting events, business conferences or even family celebrations such as weddings, christenings or communions, could be held again in larger capacities.

Common MS, a company specializing in transformation solutions for the healthcare industry; Unilabs, a leading diagnostics company in Europe and Inno&Brain, a company specializing in the field of care and clinical management; have designed a solution to gradually reactivate cultural and social life, allowing the capacity to be increased at large events, which until now, have suffered from the Covid-19 restrictions.

The initiative, a pioneer in Spain and Europe, brings together under the same technological platform the analytical-clinical, logistics and data processing capabilities provided by the three companies, to offer a solution that guarantees the health and safety of all attendees, at the same time, it responds to the needs of professionals in the sector, providing them with a security and control solution before, during and after the event.

Esteban Gebhard, Common MS´s consulting partner, explains: “This solution will provide an important and necessary economic boost to the hard-hit events sector, as well as to other ancillary business segments. With this initiative, we will be able to return to normality in the social and leisure activity of the population, which has suffered constant restrictions over the last year.”

Rainiero Holgado, Unilabs Spain, Managing Director, stated: “As a leading provider of diagnostics, we are committed to being able to contribute to the return of normality, and support cultural activity. Through the reliability and security that our tests provide, and thanks to the expertise of our partners, we will be able to offer a safe and controlled service.”

Javier Pardo, Doctor and CEO of Inno & Brain, highlighted: “The value of this solution for reactivating large events is its comprehensive approach. We do not focus on a single phase of the process, but we constantly monitor before, during and after the event. Before, with the performance of a previous antigenic test; during, with the technology that allows recording risk contacts; and later, with the clinical assessment through the virtual hospital.”

A phased control protocol to ensure the health and safety of all attendees.

The initiative, supported through the Common Virtual Hospital solution (a technological platform that manages the clinical information of patients in an encrypted way) and with national and international coverage, responds to all security and anti-Covid-19 control needs that are required before, during and after the event.

The protocol, controlled during all phases of the event, would be the following:

  1. Each ticket (purchased with phone number, name, surname, ID and email) will be associated with a barcode that will allow identification and access to the event, through the event app. Each ticket will be numbered and will be assigned a time slot to attend the event.
  2. Once there, before the event begins, attendees must undergo an antigen test carried out by Unilabs, the result of which will be communicated to the attendee fifteen minutes later through the app. Until the reception of the result, the attendee will remain in a space provided for waiting.
  3. If the result is positive, the protocol will be activated in these cases: home isolation will be recommended and the case will be notified to Public Health.
  4. If the result is negative, the attendee will be able to enter the venue. At the entrance the attendee will be provided with a new mask and a bracelet equipped with Bluetooth technology, which will manage the registering, anonymously and reliably, throughout the event, all the contacts with whom the attendee approaches within a distance of 1.5 meters.
  5. If in the 72 hours after the event, a spectator communicates to the Virtual Hospital that he has tested positive for Covid-19, the platform  would identify the risk contacts and would automatically communicate this incident to the people who were within the perimeter of personal distance, recommending that the attendee should  undergo a new test.